Search
for
Sort by
Research 541–570 of 1000+
- Pathophysiology of the Burn Scar
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Cellular Plasticity in Cutaneous Wound Healing
- POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Decreased CD200R expression on monocyte-derived macrophages correlates with Th17/Treg imbalance and disease activity in rheumatoid arthritis patients
- What′s new in cicatricial alopecia?
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- A Cell Membrane-Level Approach to Cicatricial Alopecia Management: Is Caveolin-1 a Viable Therapeutic Target in Frontal Fibrosing Alopecia?
- Update on Frontal Fibrosing Alopecia
- Cutaneous drug reactions
- Dermatological drugs, topical agents, and cosmetics
- Comparative Evaluation of Oral Baricitinib and Tofacitinib in Alopecia Areata: A Retrospective Cohort Study Based on SALT Scores
- Lichen Planopilaris
- 4. Bullous/Mucous Membrane
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- AN SYNOPTIC OVERVIEW ON AUTOIMMUNE DISORDERS AND ITS MANAGEMENT
- Antioxidants in dermatology
- p53 Involvement in the Control of Murine Hair Follicle Regression
- Beyond Expectations
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Androgen Receptor Actions Modify Skin Structure and Chemical Carcinogen-induced Skin Cancer Susceptibility in Mice
- Chapter 23. Therapeutic Control of Androgen Action
- Alopecia caused by isoniazid
- 138 Characterization of xenobiotic metabolizing enzymes of a reconstructed human epidermal model from adult hair follicles
- Farmácia Lusitana, Vila do Conde e nos Serviços Farmacêuticos do Hospital CUF, Porto
- ANAIS DO I CONGRESSO MÉDICO DE FORMOSA - COMEF
- Deep skin fibroblast-mediated macrophage recruitment supports acute wound healing
- Lentiginous melanoma. A clinically malignant entity that histopathologically seems benign. Case study harbouring BRAF V 600R mutation